Cargando…
Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management
Fatigue is the most commonly encountered symptom in patients with chronic liver disease (CLD). The resulting decrease in quality of life contributes markedly to the societal costs of fatigue. Moreover, fatigue is associated with social dysfunction, increased daytime somnolence, impaired working abil...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942008/ https://www.ncbi.nlm.nih.gov/pubmed/35371364 http://dx.doi.org/10.5114/pg.2022.114594 |
_version_ | 1784673218060091392 |
---|---|
author | Kośnik, Artur Wójcicki, Maciej |
author_facet | Kośnik, Artur Wójcicki, Maciej |
author_sort | Kośnik, Artur |
collection | PubMed |
description | Fatigue is the most commonly encountered symptom in patients with chronic liver disease (CLD). The resulting decrease in quality of life contributes markedly to the societal costs of fatigue. Moreover, fatigue is associated with social dysfunction, increased daytime somnolence, impaired working ability, and increased risk of mortality. Fatigue is not related to the severity of the underlying liver fibrosis or dysfunction. In CLD patients, fatigue manifests with both central symptoms, characterised by cognitive impairment, sleep disturbance, apathy, and autonomic dysfunction, and peripheral symptoms, characterised by decreased exercise tolerance and reduced physical activity levels. The pathogenesis of fatigue in CLD is multifactorial and involves changes in the brain–liver axis resulting from changes in inflammatory cytokines or the gut microbiome. Numerous interventions have attempted to alleviate fatigue in CLD by improving its central and peripheral manifestations or the underlying liver disease. Currently, however, there are no widely accepted or effective treatments for fatigue in CLD patients. In this review, we highlight the problem of fatigue in CLD, the current theories regarding its pathogenesis, and current approaches to its treatment. |
format | Online Article Text |
id | pubmed-8942008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-89420082022-03-31 Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management Kośnik, Artur Wójcicki, Maciej Prz Gastroenterol Review Paper Fatigue is the most commonly encountered symptom in patients with chronic liver disease (CLD). The resulting decrease in quality of life contributes markedly to the societal costs of fatigue. Moreover, fatigue is associated with social dysfunction, increased daytime somnolence, impaired working ability, and increased risk of mortality. Fatigue is not related to the severity of the underlying liver fibrosis or dysfunction. In CLD patients, fatigue manifests with both central symptoms, characterised by cognitive impairment, sleep disturbance, apathy, and autonomic dysfunction, and peripheral symptoms, characterised by decreased exercise tolerance and reduced physical activity levels. The pathogenesis of fatigue in CLD is multifactorial and involves changes in the brain–liver axis resulting from changes in inflammatory cytokines or the gut microbiome. Numerous interventions have attempted to alleviate fatigue in CLD by improving its central and peripheral manifestations or the underlying liver disease. Currently, however, there are no widely accepted or effective treatments for fatigue in CLD patients. In this review, we highlight the problem of fatigue in CLD, the current theories regarding its pathogenesis, and current approaches to its treatment. Termedia Publishing House 2022-03-18 2022 /pmc/articles/PMC8942008/ /pubmed/35371364 http://dx.doi.org/10.5114/pg.2022.114594 Text en Copyright © 2022 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY -NC -SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ).This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Review Paper Kośnik, Artur Wójcicki, Maciej Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management |
title | Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management |
title_full | Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management |
title_fullStr | Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management |
title_full_unstemmed | Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management |
title_short | Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management |
title_sort | fatigue in chronic liver disease patients: prevalence, pathophysiology, and management |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942008/ https://www.ncbi.nlm.nih.gov/pubmed/35371364 http://dx.doi.org/10.5114/pg.2022.114594 |
work_keys_str_mv | AT kosnikartur fatigueinchronicliverdiseasepatientsprevalencepathophysiologyandmanagement AT wojcickimaciej fatigueinchronicliverdiseasepatientsprevalencepathophysiologyandmanagement |